Arbutus Biopharma Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2017 to Q4 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Arbutus Biopharma Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2017 to Q4 2024.
- Arbutus Biopharma Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 186M shares, a 11.8% increase year-over-year.
- Arbutus Biopharma Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 186M shares, a 11.8% increase from 2023.
- Arbutus Biopharma Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 166M shares, a 9.95% increase from 2022.
- Arbutus Biopharma Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 151M shares, a 42.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)